Advertisement
UK markets closed

  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     

  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     

  • AIM

    745.67
    +0.38 (+0.05%)
     

  • GBP/EUR

    1.1612
    -0.0071 (-0.61%)
     

  • GBP/USD

    1.2370
    -0.0068 (-0.55%)
     

  • Bitcoin GBP

    51,906.82
    +758.83 (+1.48%)
     

  • CMC Crypto 200

    1,383.36
    +70.74 (+5.39%)
     

  • S&P 500

    4,955.84
    -55.28 (-1.10%)
     

  • DOW

    37,919.46
    +144.08 (+0.38%)
     

  • CRUDE OIL

    83.22
    +0.49 (+0.59%)
     

  • GOLD FUTURES

    2,408.40
    +10.40 (+0.43%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     

  • DAX

    17,737.36
    -100.04 (-0.56%)
     

  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     
Property:

11 beautiful homes with glorious garden rooms

Investing in a home with a garden room will enable you to enjoy your outside space whatever the weather

Coloplast A/S - Transactions in connection with share buy-back programme, week 30

Coloplast A/S
·2-min read

As mentioned in Announcement no. 02/2021 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
The programme commenced on 22 February 2021 and is expected to end by 23 August 2021.

The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.

The following transactions have been executed during the period 26 – 30 July 2021:

Date

Number of shares

Average purchase price, DKK

Transaction value, DKK

26 July 2021

300

1,121.05

336,315

27 July 2021

300

1,119.72

335,916

28 July 2021

300

1,128.32

338,496

29 July 2021

300

1,136.69

341,007

30 July 2021

2,000

1,143.10

2,286,200

Accumulated until now under the programme

414,248

976.54

404,529,596

Henceforth, Coloplast owns 3,222,021 treasury B shares of DKK 1 equal to 1.49% of the company’s total share capital.

ADVERTISEMENT

An overview showing the transaction data for the period 26 – 30 July 2021 is enclosed.

Kind regards,
Investor Relations
Coloplast A/S
Tel. +45 4911 1800

For further information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111

Ellen Bjurgert
Vice President, Investor Relations
Tel. +45 4911 1800 /+45 4911 3376
Email: dkebj@coloplast.com

Aleksandra Dimovska
Sr. Manager, Investor Relations
Tel. +45 4911 1800 / +45 4911 2458
Email: dkadim@coloplast.com

Press and the media
Peter Mønster
Sr. Media Relations Manager
Tel. +45 4911 2623
Email: dkpete@coloplast.com

Address
Coloplast A/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917

Website
www.coloplast.com


This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2021-07.

All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.

Attachments